Augmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Call Transcript

Manny Krakaris: Well, first order businesses to GA Go for both the Ambulatory and ER departments and that is coming up soon. and then to continue to iterate and improve product to make sure that we satisfy as many customers as possible with that product. And then, after that, once you get Go, you’re talking about — we’re looking at adding features to our product suite and then leveraging the open platform that we’ve been talking about, making sure that those partnerships materialize and that they start generating some impact with our customers. So we’re really excited about that. That’s going to be really central to our long-term strategic positioning in the market.

Operator: Thank you. This concludes today’s question-and-answer session. I would now like to turn the floor over to Manny Krakaris for closing comments.

Manny Krakaris: Thank you, operator. So thank you, everybody, for listening in. We look forward to getting back together to discuss fourth quarter results with you. We’re really excited, as I mentioned in my closing comments, about what lies ahead for Augmedix. And hopefully, you’ll stay tuned. Talk to you soon. Thank you.

Operator: Thank you. This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation.